Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Abrogation of FGFR signaling blocks β-catenin–induced adrenocortical hyperplasia and aldosterone production
Vasileios Chortis, Dulanjalee Kariyawasam, Mesut Berber, Nick A. Guagliardo, Sining Leng, Betul Haykir, Claudio Ribeiro, Manasvi S. Shah, Emanuele Pignatti, Brenna Jorgensen, Lindsey Gaston, Paula Q. Barrett, Diana L. Carlone, Kleiton Silva Borges, David T. Breault
Vasileios Chortis, Dulanjalee Kariyawasam, Mesut Berber, Nick A. Guagliardo, Sining Leng, Betul Haykir, Claudio Ribeiro, Manasvi S. Shah, Emanuele Pignatti, Brenna Jorgensen, Lindsey Gaston, Paula Q. Barrett, Diana L. Carlone, Kleiton Silva Borges, David T. Breault
View: Text | PDF
Research Article Cardiology Endocrinology

Abrogation of FGFR signaling blocks β-catenin–induced adrenocortical hyperplasia and aldosterone production

  • Text
  • PDF
Abstract

Fibroblast growth factor receptors (FGFRs) are tyrosine kinase receptors critical for organogenesis and tissue maintenance, including in the adrenal gland. Here we delineate the role of FGFR2 in the morphogenesis, maintenance, and function of the adrenal cortex with a focus on the zona glomerulosa (zG). zG-specific Fgfr2 deletion (Fgfr2-cKO) resulted in impaired zG cell identity, proliferation, and transdifferentiation into zona fasciculata (zF) cells during postnatal development. In adult mice, induced deletion of Fgfr2 led to loss of mature zG cell identity, highlighting the importance of FGFR2 for the maintenance of a differentiated zG state. Strikingly, Fgfr2-cKO was sufficient to fully abrogate β-catenin–induced zG hyperplasia and to reduce aldosterone levels. Finally, short-term treatment with pan-FGFR small molecule inhibitors suppressed aldosterone production in both WT and β-catenin gain-of-function mice. These results demonstrate a critical role for FGFR signaling in adrenal morphogenesis, maintenance, and function and suggest that targeting FGFR signaling may benefit patients with aldosterone excess and/or adrenal hyperplasia.

Authors

Vasileios Chortis, Dulanjalee Kariyawasam, Mesut Berber, Nick A. Guagliardo, Sining Leng, Betul Haykir, Claudio Ribeiro, Manasvi S. Shah, Emanuele Pignatti, Brenna Jorgensen, Lindsey Gaston, Paula Q. Barrett, Diana L. Carlone, Kleiton Silva Borges, David T. Breault

×

Figure 2

Inducible KO of Fgfr2 (Fgfr2-icKO) in adults leads to a loss of zG cell identity.

Options: View larger image (or click on image) Download as PowerPoint
Inducible KO of Fgfr2 (Fgfr2-icKO) in adults leads to a loss of zG cell ...
(A) Schematic of ASCreER induction with tamoxifen. (B) Representative images of GFP and DAB2 coimmunostaining in adrenal glands from adult ASCreER/+ R26RmTmG/+ (Ctrl) and ASCreER/+ Fgfr2fl/fl R26RmTmG/+ (Fgfr2-icKO) mice at 10 weeks of age (4 weeks after tamoxifen). White arrowheads point to GFP and DAB2–copositive cells. (C) Quantification of DAB2 and GFP–copositive cells as a proportion of total GFP+ zG cells in male and female Ctrl and Fgfr2-icKO (icKO) mice. Adrenal glands from male mice are represented with black dots; adrenal glands from female mice are represented with magenta dots. Student’s t test, ***P < 0.001, n = 7, 5, respectively. (D) Representative images of GFP and AS coimmunostaining in adrenal glands from adult Ctrl and Fgfr2-icKO mice at 10 weeks of age (4 weeks post tamoxifen). White arrowheads point to GFP and AS–copositive cells. (E) Quantification of GFP and AS–copositive cells as a proportion of total GFP+ zG cells in male and female Ctrl and Fgfr2-icKO mice. Adrenal glands from male mice are represented with black dots; adrenal glands from female mice are represented with magenta dots. Student’s t test, ***P < 0.001, n = 6, 6, respectively. Scale bars: 50 μm. DAPI (blue), nuclei. Dashed white lines correspond to the zG-zF boundary.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts